Opportunities in Global Bioseparation System Market
April 05, 2017
Wellesley, Mass., Apr 05, 2017 – New proprietary research by BCC Research anticipates that increasing research in the life sciences and newer technological developments should boost the bioseparation global market by $5 billion from 2016-2021.The market should reach nearly $24.0 billion in the end year on a projected 4.7% CAGR.
BCC Research's Separation Systems for Commercial Biotechnology reports that modern industries have begun to explore the advantages of bioseparation systems in their production processes, which have led to a steady market. Research and development spending along with increasing competition and patent expiries are giving a new direction to the market.
Research Highlights
- Microfluidics and nano-fluidics are growing the lab-on-a-chip segment.
- Liquid chromatography as a segment is growing due to increased usage in research and clinical laboratories.
- The rising demand for biosimilars is expanding the chromatographic separations market.
"Modern industries have now begun to explore the advantages of bioseparation systems in their production processes, which have led to a steady market," says Kevin Fitzgerald, BCC Research editorial director. "Research and development spending, along with increasing competition and patent expiries are giving a new direction to the market."
Big Opportunities for Market Growth
The market has significant opportunities to expand and broaden due to the new technologies available in the market. The market entails continuous bioprocessing equipment and biomarkers. Traditional separation methods are being continuously modified to keep up with the demands.
"Single–use technologies and disposable techniques have improved over time, as with single-use continuous chromatography," says Fitzgerald. "Its development and improvement provides accuracy and precise data analysis, good functionality, reliability and cost efficiency. BCC Research predicts rising demand for bioseparation systems like chromatography, flow cytometer, and membrane filtration. Also, the demand for high quality reagents is expected to increase in respect to development of new drugs and different clinical tests. The market is moving, for sure."
Editors and reporters who wish to speak with the analyst should contact Steven Cumming at steven.cumming@bccresearch.com.
Separation Systems for Commercial Biotechnology( BIO011G )
Publish Date: Mar 2017
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Cell Biology
- Decentralized Clinical Trials Market to Reach $18.8 Billion by 2030 as Digital Health Infrastructure Reshapes Drug Development
- Global Botanical and Plant-Derived Drug Market Projected to Hit $58.1 Billion by 2030
- Global Protein Expression Market Poised for 10.9% CAGR Expansion by 2030
- BCC Research Forecasts 7.5% CAGR for Global Biological Cancer Therapies Market
- Fusion Proteins Market to Hit $64.9 Billion by 2030
Reports from Cell Biology
- Global DNA Read, Write, and Edit Market
- Validation, Calibration, and Standardization in the Life Sciences Market
- Cloud Computing in Cell Biology, Genomics and Drug Development: Global Markets
- Decentralized Clinical Trials: Global Markets
- Central Nervous System (CNS) Biomarkers: Technologies and Global Markets
Recent News
- Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
- Long-Term Care and Home Healthcare Technology Market to Reach $64.8 Billion by 2030 as Aging Demographics and Remote Monitoring Reshape Care Delivery
- Radioligand Therapeutics Market to More Than Double to $4.8 Billion by 2030 as Targeted Cancer Treatments Gain Regulatory Momentum
- Global GLP-1 Analogues Market to Reach $268.4 Billion by 2030
- AI in Clinical Trials Poised for Rapid Growth with a 22.6% CAGR Forecast